首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Pathology >Expression of NF-κB and PTEN in primary epithelial ovarian carcinoma and the correlation with chemoresistance
【2h】

Expression of NF-κB and PTEN in primary epithelial ovarian carcinoma and the correlation with chemoresistance

机译:NF-κB和PTEN在原发性上皮性卵巢癌中的表达及其与化学耐药性的关系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study aims to investigate the relationship of NF-κB p65 and PTEN protein with chemotherapy resistance in ovarian cancer by measuring their expression in primary epithelial ovarian cancer, and to explore the correlation of the expression of these two proteins with ovarian carcinoma and their clinical significance. Ovarian cancer patients (n = 161) were divided into two groups: sensitive group (n = 82) and resistant group (n = 79). Expression of NF-κB p65 and PTEN protein in the ovarian cancer tissues was determined using immunohistochemistry to assess the relationship and correlation between the expression levels of these two proteins and chemotherapy resistance of ovarian carcinoma. The Cox model was used to analyze the independent risk factors associated with ovarian cancer prognosis. The expression of NF-κB p65 in the sensitive group (68.29%) was lower than that of the resistant group (94.94%). In contrast, the expression of PTEN protein in the sensitive group (50.00%) was higher than that of the resistant group (17.72%). Expression of NF-κB p65 was negatively correlated with that of PTEN protein in ovarian cancer tissue (rs = -0.246, P = 0.002). Expression of NF-κB p65 or PTEN protein and surgical stage of ovarian cancer were independent risk factors associated with chemoresistance (all P < 0.05). Low expression of PTEN and high expression of NF-κB are significant risk factors for chemotherapy resistance of ovarian cancer patients.
机译:本研究旨在通过检测原发性上皮性卵巢癌中NF-κBp65和PTEN蛋白与卵巢癌化疗耐药的关系,探讨这两种蛋白在卵巢癌中的表达及其临床意义。意义。卵巢癌患者(n = 161)分为两组:敏感组(n = 82)和耐药组(n = 79)。用免疫组织化学方法检测NF-κBp65和PTEN蛋白在卵巢癌组织中的表达,以评估这两种蛋白的表达水平与卵巢癌化疗耐药的关系。 Cox模型用于分析与卵巢癌预后相关的独立危险因素。敏感组中NF-κBp65的表达(68.29%)低于耐药组(94.94%)。相比之下,敏感组中PTEN蛋白的表达(50.00%)高于耐药组(17.72%)。卵巢癌组织中NF-κBp65的表达与PTEN蛋白的表达呈负相关(rs = -0.246,P = 0.002)。 NF-κBp65或PTEN蛋白的表达以及卵巢癌的手术分期是与化学耐药性相关的独立危险因素(所有P <0.05)。 PTEN的低表达和NF-κB的高表达是卵巢癌患者化疗耐药的重要危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号